company-logo

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

ClearPoint Neuro Dividend Announcement

ClearPoint Neuro does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on ClearPoint Neuro dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

ClearPoint Neuro Dividend History

ClearPoint Neuro Dividend Yield

ClearPoint Neuro current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing ClearPoint Neuro stock? Use our calculator to estimate your expected dividend yield:

ClearPoint Neuro Financial Ratios

P/E ratio-17.74
PEG ratio-0.57
P/B ratio11.10
ROE-62.10%
Payout ratio0.00%
Current ratio4.54
Quick ratio3.61
Cash Ratio2.86

ClearPoint Neuro Dividend FAQ

Does ClearPoint Neuro stock pay dividends?
ClearPoint Neuro does not currently pay dividends to its shareholders.
Has ClearPoint Neuro ever paid a dividend?
No, ClearPoint Neuro has no a history of paying dividends to its shareholders. ClearPoint Neuro is not known for its dividend payments.
Why doesn't ClearPoint Neuro pay dividends?
There are several potential reasons why ClearPoint Neuro would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will ClearPoint Neuro ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While ClearPoint Neuro has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is ClearPoint Neuro a dividend aristocrat?
ClearPoint Neuro is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is ClearPoint Neuro a dividend king?
ClearPoint Neuro is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is ClearPoint Neuro a dividend stock?
No, ClearPoint Neuro is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy ClearPoint Neuro stocks?
To buy ClearPoint Neuro you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy ClearPoint Neuro stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.